| Primary |
| Epstein-barr Virus Infection |
50.0% |
| Pneumonia Measles |
50.0% |
|
| Pseudomonas Test Positive |
50.0% |
| Viral Myocarditis |
50.0% |
|
| Secondary |
| Renal Transplant |
10.8% |
| Haematology Test Abnormal |
8.6% |
| Dermatomyositis |
8.2% |
| Autoimmune Thrombocytopenia |
7.8% |
| Immunosuppression |
7.8% |
| Idiopathic Thrombocytopenic Purpura |
6.9% |
| Gastrooesophageal Reflux Prophylaxis |
5.2% |
| Prophylaxis Against Transplant Rejection |
5.2% |
| Status Epilepticus |
5.2% |
| Wegener's Granulomatosis |
5.2% |
| Antiemetic Supportive Care |
4.3% |
| Pemphigus |
4.3% |
| Relapsing-remitting Multiple Sclerosis |
3.9% |
| Multiple Sclerosis |
3.0% |
| Graft Versus Host Disease |
2.6% |
| Transplant Rejection |
2.6% |
| Antiviral Prophylaxis |
2.2% |
| Autoimmune Disorder |
2.2% |
| Dermatitis Herpetiformis |
2.2% |
| Fungal Infection |
2.2% |
|
| Vaginal Haemorrhage |
8.5% |
| Weight Increased |
8.5% |
| Graft Loss |
6.4% |
| Haemorrhage |
6.4% |
| Multiple Sclerosis |
6.4% |
| Premature Baby |
6.4% |
| Rash Maculo-papular |
6.4% |
| Thrombocytosis |
6.4% |
| Calcinosis |
4.3% |
| Headache |
4.3% |
| Melaena |
4.3% |
| Rectal Haemorrhage |
4.3% |
| Septic Shock |
4.3% |
| Systemic Lupus Erythematosus |
4.3% |
| Thrombocytopenia |
4.3% |
| Transplant Rejection |
4.3% |
| Urinary Tract Infection |
4.3% |
| Caesarean Section |
2.1% |
| Dyskinesia Oesophageal |
2.1% |
| Haemoglobin Decreased |
2.1% |
|
| Concomitant |
| Idiopathic Thrombocytopenic Purpura |
57.7% |
| Product Used For Unknown Indication |
6.7% |
| Multiple Myeloma |
4.7% |
| Drug Use For Unknown Indication |
3.8% |
| Immunosuppression |
2.5% |
| Prophylaxis |
2.2% |
| Prophylaxis Against Graft Versus Host Disease |
2.2% |
| Thrombocytopenia |
2.2% |
| Hypertension |
2.2% |
| Pain |
2.2% |
| Asthma |
1.7% |
| Kawasaki's Disease |
1.5% |
| Pneumonia |
1.5% |
| Systemic Lupus Erythematosus |
1.5% |
| Acute Lymphocytic Leukaemia |
1.5% |
| Surgical Preconditioning |
1.2% |
| Aspergillosis |
1.2% |
| Immune Thrombocytopenic Purpura |
1.2% |
| Infection Prophylaxis |
1.1% |
| Multiple Sclerosis |
1.1% |
|
| Drug Ineffective |
17.4% |
| Therapeutic Response Decreased |
16.7% |
| Thrombocytopenia |
13.3% |
| Death |
7.9% |
| Platelet Count Decreased |
5.2% |
| Bone Marrow Reticulin Fibrosis |
4.4% |
| Myelodysplastic Syndrome |
3.9% |
| Hospitalisation |
3.2% |
| Pulmonary Embolism |
3.2% |
| Sepsis |
2.9% |
| Deep Vein Thrombosis |
2.7% |
| Weight Decreased |
2.7% |
| Pyrexia |
2.5% |
| Platelet Count Increased |
2.2% |
| Thrombosis |
2.2% |
| Vomiting |
2.2% |
| Headache |
2.0% |
| Infection |
2.0% |
| Multi-organ Failure |
1.7% |
| Renal Impairment |
1.7% |
|
